Tuesday May 8 | AmericanBankingNews.com
Benchmark Co. Analysts Begin Coverage on Vascular Solutions
The firm set a "buy" rating and a $15.00 price target on the stock. A number of other firms have also recently commented on VASC.
UPDATE 1-Vascular Solutions profit beats estimates
Medical device maker Vascular Solutions Inc posted a quarterly profit that beat market estimates by a cent, helped by strong sales of its coronary devices.
Vascular Solutions CEO Howard Root gets pay raise
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings.